Session » Miscellaneous Rheumatic and Inflammatory Diseases Poster Session II

Abstract Number: 1379

High Serum IgG4 Concentration Is a Risk Factor for Relapse in IgG4-Related Disease

Abstract Number: 1380

Characterization of Lymphocytes Subsets in Peripheral Blood of Untreated IgG4-Related Disease Patients

Abstract Number: 1381

The Relationship Between Serum Cholinesterase, Number of Organ Involvement and Fibrotic Markers in Japanese Patients with IgG4-Related Disease

Abstract Number: 1382

Clinical and Serum IgG4 Characteristics of a Unique British Columbian IgG4-Related Disease Cohort

Abstract Number: 1383

T-Cell Subset Analysis in IgG4-Related Disease and Lymphocyte-Variant Hypereosinophilic Syndrome

Abstract Number: 1384

Comparison of IgG4-Related and Non-IgG4-Related Retroperitoneal Fibrosis; A 12 Year Retrospective Study

Abstract Number: 1385

Efficacy and Tolerance of Rituximab in IgG4-Related Disease: A Retrospective Multicentric Study in 24 Patients

Abstract Number: 1386

Malignancy Prevalence Is Increased Among Patients before the Onset of IgG4-Related Disease

Abstract Number: 1387

Thoracic Paravertebral Masses and IgG4-Related Disease: Report of 8 Cases and Review of the Literature

Abstract Number: 1388

Adalimumab in Patients with Inactive, Non-Infectious Uveitis Requiring Systemic Treatment

Abstract Number: 1389

A Meta-Analysis of the Prevalence of the Ocular Manifestations in All Inflammatory Rheumatic Diseases

Abstract Number: 1390

Hidradenitis Suppuritiva Is Associated with Inflammatory Eye Disease

Abstract Number: 1391

Differential Expression of Interferon Gamma in Exudate from Hidradenitis Suppurativa Lesions Compared to Chronic Wounds

Abstract Number: 1392

Azathioprine May be an Effective Steroid Sparing Agent in Patients with Isolated Recurrent Pericarditis

Abstract Number: 1393

Diagnostic Categorization of Ocular Sarcoidosis Based on the International Criteria Proposed By the First International Workshop on Ocular Sarcoidosis. a Case Series of 11 Spanish Patients

Abstract Number: 1394

Clinical Characteristics of Sarcoid Arthropathy: A Population-Based Study

Abstract Number: 1395

Prevalence and Significance of MEFV GENE Mutations in Patients with Sarcoidosis

Abstract Number: 1396

Long Term Outcome of Neurosarcoidosis

Abstract Number: 1397

Successful Treatment of Cardiac Sarcoidosis with Biologic and Immunosuppressive Combination Therapy

Abstract Number: 1398

Musculoskeletal and Serologic Findings in an Adult Cystic Fibrosis Clinic Population-a Systematic Review and Collation with Disease Status

Abstract Number: 1399

Patterns of Arthropathy in Patients with Cystic Fibrosis

Abstract Number: 1400

Hyperferritinemia and Fever in Adults

Abstract Number: 1401

Is There Any Difference Between Autoimmune or Hemato-Oncology Etiology of Macrophage Activation Syndrome?

Abstract Number: 1402

Development of Systemic Juvenile Idiopathic Arthritis Manifestations Following Remission of Hemophagocytic Lymphohistiocytosis

Abstract Number: 1403

Immune Related Adverse Events Associated with Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review of Case Reports

Abstract Number: 1404

Death and Infection Rates Appear Reduced in a Modern Cohort of ICU Patients with Rheumatic Disease

Abstract Number: 1405

Tocilizumab Serum Levels and Antidrug Antibodies and Its Relationship with Disease Activity in Rheumatic Diseases

Abstract Number: 1406

The Treatment of Undifferentiated Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Abstract Number: 1407

New Clinical Features of Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne Syndrome

Abstract Number: 1408

Cogan Syndrome: Differential Response to Biologic Agents and Role of PET-CT in the Increased Diagnosis of Aortitis

Abstract Number: 1409

Subglottic Stenosis: A Unique Inflammatory Disorder